Clinical trial
Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist
NCT00303394 · University of Zurich, Other · Completed
Key facts
| NCT number | NCT00303394 |
|---|---|
| Title | Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist |
| Official title | Phase 2 Study of IL-1Ra in Patients With Type 2 Diabetes |
| Lead sponsor | University of Zurich, Other |
| Collaborators | Steno Diabetes Center Copenhagen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | IL-1Ra |
| Enrollment | 72 |
| Start date | Apr 1, 2004 |
| Completion | Mar 1, 2006 |
| First posted | Mar 16, 2006 |
| Last update posted | Mar 5, 2007 |
| Countries | Denmark, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: